Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)

NCT01830959 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT01830959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2013
Completion date
October 31, 2016
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis